²»Á¼Ñо¿Ëù

News

Stay up to date on the latest company news:
09 October 2024

²»Á¼Ñо¿Ëù Appoints Gerben Moolhuizen as Chief Executive Officer

18 March 2024

²»Á¼Ñо¿Ëù selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)

18 October 2022

²»Á¼Ñо¿Ëù Appoints Thomas Bogenrieder as Chief Medical Officer

12 August 2022

²»Á¼Ñо¿Ëù---arenaviruses take on cancer

14 October 2021

²»Á¼Ñо¿Ëù Completes Series A Extension Bringing Total Raised to EUR 43 Million

05 February 2020

²»Á¼Ñо¿Ëù Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts

15 October 2019

²»Á¼Ñо¿Ëù Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer

Events

Want to get in touch with the ²»Á¼Ñо¿Ëù Team? Meet us at the following events:
February 26-27, 2025

Sachs Associates 18th Annual European Life Sciences CEO Forum

Location: Zurich, Switzerland

Presentation: Oral company presentation

Presenters: Gerben Moolhuizen, CEO

Date: February 26-27, 2025

March 12-14, 2025

SITC Spring Scientific

Location: San Diego, USA

Poster Presentation: Arenavirus immunotherapy induces favorable anti-tumor immune mechanisms improving checkpoint and cell therapies

Presenter: Ulrike Köhler, Senior Scientist

Date: March 12-14, 2025

May 12-14, 2025

22nd CIMT Annual Meeting

Location: Mainz, Germany

Poster Presentation

Presenter: Maria Hønholt Christensen; Research Scientist

Date: May 12-14, 2025

May 12-14, 2025

Bio€quity Europe

Location: Bruges, Belgium

Participant: Gerben Moolhuizen, CEO

Date: May 12-14, 2025

June 16-19, 2025

BIO International Convention

Location: Boston, USA

Participant: Gerben Moolhuizen, CEO

Date: June 16-19, 2025